EMA Sees Benefits of Interaction with Japanese Regulators

The Agency has increased its level of interaction and cooperation with medicines regulatory authorities in Japan over the past three years.

The European Medicines Agency has increased its level of interaction and cooperation with medicines regulatory authorities in Japan over the past three years, according to the report on interactions published this week.

Since November 2009, when the Japanese authorities seconded their first liaison official to the Agency, there has been an increase in information exchange and interaction on areas of mutual interest, with Japanese and European representatives attending conferences and meetings in each others' territories.

The presence of a new liaison officer from Japan continues to provide a strong basis for mutual education, awareness of opportunities for interaction and communication between the European and Japanese authorities, helping to address public-health issues and avoi